Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02965638 · ClinicalTrials.gov registry record · NA
Trial of Maternal Oxygen for Fetal Left Heart Hypoplasia
A NA study of Fetal Left Heart Hypoplasia, sponsored by Shaine Morris.
- Active
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT02965638 is a NA study of Fetal Left Heart Hypoplasia that is active but no longer recruiting, run by Shaine Morris. The registered enrollment target is 12 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02965638, a NA study of Fetal Left Heart Hypoplasia, is active but no longer recruiting, sponsored by Shaine Morris.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if maternal hyperoxygenation is an effective treatment for fetal left heart hypoplasia versus room air (placebo). This will be determined by measuring how well a baby's heart valves and their surrounding tissue are growing and functioning. In addition the investigators will examine brain growth using fetal ultrasound and MRI, and MRI of the child's brain after they are born to determine if there is greater neonatal brain maturity or mothers receiving oxygen compared to fetuses of mothers not receiving oxygen. Of note, the trial was initially randomized. However, due to low sample size and hesitation about randomization, the trial was converted to an open label study, allowing families opting for oxygen therapy to be in the intervention arm.
Conditions Studied
Interventions
- OTHER Oxygen
Study Locations (1)
Texas
- Texas Children's Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2015-09 |
| Est. Completion | 2027-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02965638
The ClinicalTrials.gov registry entry for NCT02965638 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shaine Morris, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Fetal Left Heart Hypoplasia appearing as the primary indexed condition, and to 1 intervention - of which Oxygen is the first listed.
NCT02965638 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT02965638 about?
NCT02965638 is a clinical study titled "Trial of Maternal Oxygen for Fetal Left Heart Hypoplasia". The purpose of this study is to determine if maternal hyperoxygenation is an effective treatment for fetal left heart hypoplasia versus room air (placebo). This will be determined by measuring how well a baby's heart valves and their surrounding tissue are growing and functioning. In addition the i...
What is the current status of trial NCT02965638?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2015-09. Estimated completion is 2027-07.
What conditions does trial NCT02965638 study?
This clinical trial studies the following conditions: Fetal Left Heart Hypoplasia.
What interventions are being tested in trial NCT02965638?
The interventions under investigation include: Oxygen (OTHER).
Who is sponsoring clinical trial NCT02965638?
This trial is sponsored by Shaine Morris, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02965638 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.